| α-SMA | Smooth muscle actin |
| ACC | Acetyl-CoA carboxylase |
| Asn | Asparagine |
| ASNS | Asparagine synthetase |
| BC | Breast cancer |
| BFAL1 | Bacteroides fragilis lncRNA1 |
| BRAFi | B-Raf Protein Kinase Inhibitors |
| CAAs | Cancer-associated adipocytes |
| CAFs | Cancer-associated fibroblasts |
| ccRCC | Clear cell renal carcinoma |
| COLI | Collagen-I |
| COLIV | Collagen-IV |
| CSCs | Cancer stem cells |
| CtBP | C-terminal Binding Protein |
| D6PD | 6-Phosphogluconate Dehydrogenase |
| DATS | Diallyl trisulfide |
| DDR | Discoidin domain receptor |
| DDR2 | Discoidin domain receptor 2 |
| dNTPs | Deoxyribonucleoside triphosphates |
| EGF | Epidermal growth factor |
| EGFRs | Surface receptors for EGF |
| EMP | E/M plasticity |
| EMT | Epithelial-mesenchymal transition |
| ENAH | Enabled Homolog |
| ERK1/2 | Extracellular signal–regulated kinase1 and 2 |
| ERRα | Estrogen-related receptor α |
| ESRP | Epithelial splicing regulatory protein |
| Evs | Extracellular vesicles |
| EZH2 | Enhancer of Zeste Homolog 2 |
| FAK | Focal adhesion kinase |
| FASN | Fatty acid synthase |
| FBP1 | Fructose-1,6-bisphosphatase 1 |
| FGF | Fibroblast growth factor |
| FGFR2IIIc | Epithelial-Type IIIb isoform to the mesenchymal-like IIIc isoform |
| FGFRs | FGF receptors |
| Gln | Glutamine |
| GRHL2 | Grainyhead-like 2 |
| GLS1 | Glutaminase 1 |
| GSH | Glutathione |
| H3K27ac | Histone H3 acetylated at lysine 27 |
| H3K4Me3 | H3 lysine 4 trimethylation |
| H3K36Me3 | H3 lysine 36 trimethylation |
| HCC | Hepatocellular carcinoma |
| HDACs | Histone Deacetylases |
| HIFs | Hypoxia-inducible factors |
| HGF | Hepatocyte growth factor |
| HNSCC | Head-and-neck squamous cell carcinoma |
| HREs | Hypoxia response elements |
| iCAF | Inflammatory cancer-associated fibroblasts |
| Ig | Immunoglobulin |
| IGF-1R | Insulin-like growth factor-1R |
| IKK | IκB kinase |
| iNOS | Induced nitric oxide synthase |
| JMJD3 | Lysine (K)-specific demethylase 6B |
| JNK | Jun N-terminal kinase |
| lncRNAs | Long non-coding RNAs |
| LOCKs | Large Organized Chromatin K9-modified Domains |
| LOX | Lysyl oxidase |
| LUAD | Lung adenocarcinoma |
| LZTR1 | Leucine zipper-like transcriptional regulator 1 |
| MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 |
| MAPKi | MAP Kinase Inhibitors |
| Mbd3/NuRD | Methyl CpG-binding domain/3 Mi-2/nucleosome remodeling and deacetylase complex |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDSCs | Myeloid-derived suppressor cells |
| MET | Mesenchymal-epithelial transition |
| myCAFs | Myofibroblastic cancer-associated fibroblasts |
| NF-κB | Nuclear factor κ-light-chain-enhancer of activated B cells |
| NICD | NOTCH intracellular domain |
| OPG | Osteoprotegerin |
| OS | Overall survival |
| PAAD | Pancreatic ductal adenocarcinoma |
| PC | Prostate cancer |
| PFS | Progression-free survival |
| PKA | Protein kinase A |
| POSTN | Periostin |
| pO2 | Oxygen partial pressure |
| PPP | Pentose phosphate pathway |
| PRC2 | Polycomb Repressive Complex 2 |
| PTX3 | Long pentraxin-3 |
| pVHL | Von Hippel-Lindau protein |
| PyM | Pyrimidine metabolism |
| ROS | Reactive oxygen species |
| SCD | Stearoyl-CoA desatuRase |
| SGOC | Serine/glycine one-carbon |
| SNHG15 | Small nucleolar RNA host gene 15 |
| SPARC | Secreted protein acidic and rich in cysteine |
| SRSF1 | Serine/arginine-rich Splicing Factor 1 protein |
| SSP | Serine synthesis pathway |
| SUZ12 | Suppressor of Zeste 12 |
| TACE | TNF-α converting enzyme |
| TAK1 | Transforming growth factor-activating kinase 1 |
| TCF2 | Transcription factor 2 |
| TGFβ | Transforming growth factor β |
| TME | Tumor microenvironment |
| TMEM | Microenvironment metastasis |
| TNF-α | Tumor necrosis factor α |
| UPR | Unfolded Protein Response |